Please login to the form below

Not currently logged in
Email:
Password:

tuberculosis

This page shows the latest tuberculosis news and features for those working in and with pharma, biotech and healthcare.

Pharma must do more on antibiotic resistance, Davos meeting hears

Pharma must do more on antibiotic resistance, Davos meeting hears

for AMR and bring them to market responsibly, ”citing the case of J&J’s new tuberculosis drug bedaquiline which is available in 100 countries with tight control of access.

Latest news

More from news
Approximately 16 fully matching, plus 125 partially matching documents found.

Latest Intelligence

  • The cultural construction of illness The cultural construction of illness

    and ‘consumptive’appearance, driven by the perception of a link between tuberculosis and creativity.

  • Reactivating drug research programmes Reactivating drug research programmes

    One research-led breakthrough to hit the headlines involves the use of genome sequencing to isolate different strains of tuberculosis (TB), allowing the disease to be diagnosed more quickly.

  • Deal Watch February 2016 Deal Watch February 2016

    acquisition - company. 7, 200. Alere/Abbott Laboratories. portfolio of point of care diagnostics for infections such as HIV, tuberculosis, malaria, dengue.

  • Searching for health Searching for health

    We bring products to the market regularly.”. Success in HIV and multi-drug resistant tuberculosis are the highlights but Quiles is conscious of the need to translate innovation into market penetration.

  • The AMR threat The AMR threat

    country. The misuse and overuse of antibiotics in humans and animals is causing resistance to accelerate and leading to a growing number of infections - among them pneumonia, tuberculosis and gonorrhoea - becoming

More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
WCG

WCG is an independent, global agency specialising in healthcare communications. Our value as a company is about being the positive...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics